Ly300164 (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
6 | Parkinson disease | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00004576 (ClinicalTrials.gov) | February 2000 | 17/2/2000 | Study of LY300164 for the Treatment of Parkinson's Disease | AMPA Receptor Blockade With LY300164 in the Treatment of Parkinson's Disease | Dyskinesias;Parkinson Disease | Drug: LY300164 | National Institute of Neurological Disorders and Stroke (NINDS) | NULL | Completed | N/A | N/A | Both | 20 | Phase 2 | United States |